Turmeric is a spice with antioxidant and anti-inflammatory properties. It may help to treat various types of pain, including ...

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

Despite various treatments, the first-line approach for rheumatoid arthritis (RA) has long relied on disease-modifying ...

Fintel reports that on July 23, 2025, Craig-Hallum initiated coverage of Exagen (NasdaqGM:XGN) with a Buy recommendation.

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

Autoimmune diseases are on the rise. We sit down with Dr. Robert Kimelheim of TidalHealth to talk rheumatoid arthritis and ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

Medicare drug plans may cover Rinvoq, but the specifics of coverage and out-of-pocket costs can differ depending on a person's specific plan.

The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

The investment bank said that Exagen is poised for growth with a differentiated autoimmune test that outperforms conventional biomarker-based tests.